Neuberger Berman Group’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18K | Hold |
|
|||||
|
2025
Q1 | $19.4K | Hold |
|
|||||
|
2024
Q4 | $31.4K | Hold |
|
|||||
|
2024
Q3 | $14.6K | Hold |
|
|||||
|
2024
Q2 | $13.9K | Buy |
|
|||||
|
2024
Q1 | $15.5K | Sell |
|
|||||
|
2023
Q4 | $19.1K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $1.19M | Buy |
|
|||||
|
2016
Q4 | $353K | Hold |
|
|||||
|
2016
Q3 | $333K | Buy |
|